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Summary: The diagnostic validity of multivariate combinations of oci-antitrypsin, a2-macroglobulin, C-reactive
protein, complement C3, complement C4, neopterin in serum, and neopterin in urine as markers for acute
cardiac allograft rejection and for differential diagnosis of rejection and infections was investigated in the
follow-up of 37 patients with heart transplants. Rejection was diagnosed by endomyocardial biopsy. Infections
were classified as 'no infection', 'viral infection', and 'bacterial, fungal or mixed infections'. Although there
are significant differences between the mean levels of analytes, multivariate discriminant analysis does not
provide an adequate discrimination of rejection and infection states. In separate rejection diagnosis, multi-
variate combinations of analytes cannot replace endomyocardial biopsy. However, a multivariate combination
of -anti trypsin, a2^macroglobulin, C-reactive protein, C3, C4 in serum, and neopterin in urine can be used
as a screening procedure to reduce the number of endomyocardial biopsies.
Introduction
Heart transplantation has become an accepted In an early study we investigated the diagnostic va-
methöd in the treatment of patients with end-stage lidity of some biochemical analytes which were in-
heart diseases (1). Despite significant improvements volved in the rejection process (10). We found that
in the clinical management of heart transplant recip- oci-antiproteinase (oci-antitrypsin), C-reactive protein,
ients by immunosupporession with cyclosporin A, a2-macroglpbulin, complement components C3 and
rejection still remains a major problem. Rejection C4 in serum, and neopterin in urine have some dis-
needs special treatment, the success*of which depends criminatory power in rejection diagnosis, but in all
on early recognition. Although some non-invasive cases it was too weak for a reliable exclusion or
techniques have been suggested (e.g. I.e. (2 — 5)), no confirmation of rejection in need of treatment. In
methods exist for a reliable early diagnosis of rejection practice, the diagnosis of rejection is complicated by
episodes. A reliable diagnosis can be made only by bacterial, viral or fungal infections, which are frequent
percutaneous transvenous right ventricular endomyo- in patients under immunosuppressive treatment, and
cardial biopsy (6—8). This is an invasive technique which additionally influence the analytes. In this study
and it carries the risk of complications (9). A non- we investigated whether multivariate combinations of
invasive method which would adequately replace or analytes might allow a reliable detection of cardiac
at least reduce the number of endomyocardial biopsies allograft rejection and its discrimination from infec-
would be very useful. tions.
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Materials and Methods
Patients
Our group consisted of 37 patients (35 men and 2 women), age
10-55 years in the follow-up after orthotopic heart transplan-
tation carried out at the 2nd Department of Surgery, University
of Vienna. Routine immunosuppression consisted of cyclo-
sporin A and azathioprine according to the Standford scheme
(11). All patients had normal renal functions. Three patients
which developed renal failure after transplantation in the course
of treatment were not included in our study.
Rejection state
The rejection state of the patients was diagnosed by endomyo-
cardial biopsy. Endomyocardial biopsies were performed ac-
cording to Caves et al. (6, 7) and judged according to Billingham
(8). Biopsies were taken weekly during the 1st month after
operation, fortnightly during the 2nd month, monthly up to
the 6th month, and thereafter once per year. Biopsies were also
taken if there was any clinical suspicion of rejection. We in^
eluded only biopsies taken later than 3 weeks after transplan-
tation to avoid the influence of primary healing on the analytes.
We excluded control biopsies taken during the treatment of an
acute rejection to exclude the influence of therapy (high dosage
of methylprednisplone).
Infection state
The diagnosis of infections was based on clinical symptoms and
repeated bacteriological and serological tests such as blood and
urine cultures, IgM- and IgG-titres, complement binding reac-
tions, and virus isolations.
Analytical methods
The serum proteins, arantitrypsin, a2-macroglobulin, C3, and
C4, were determined nephelometrically (Behring N-reagent,
Behring Laser Nephelometer, Behringwerke AG, Marburg/
FRG). C-reactive protein (CRP) as also analysed nephelome-
trically with NA latex-CRP Reagent (Behringwerke AG).
Neopterin in serum and urine were determined by a radio-
immunoassay (Henning, Berlin).
Statistical methods
The original values of the analytes were not normally distrib-
uted, while the transformed values (log x) are approximately
normally distributed. Because analysis of variance and discrim-
inant analysis require approximately normally distributed var-
iables, we used these transformed values for calculations. For
comparison of the mean values of both rejection states A and
B in the infection groups we used Student's t-test. For compar-
ison of the mean values of the three infection states in the
rejection groups we used variance analyses and Scheffe's mul-
tiple-comparison procedure. To check the diagnostic validity of
a multivariate approach for differentiating between the two
rejection states in the infection groups, as well as for differen-
tiating between infection and rejection states, we performed
discriminant analyses using the SAS-system procedure Discrim
(12). The observations were classified into the diagnostic group
with the highest posterior probability. The prior probabilities
were assumed to be equal.
Criteria of diagnostic validi ty
The criteria commonly used to judge the diagnostic validity of
a biochemical test are diagnostic sensitivity, diagnostic specific-
ity, and predictive values of the positive and the negative tests
(13, 14). These criteria are valid for a two class problem.
Because rejections are combined with infection states, there
were more than two diagnostic classes in our study. To differ-
entiate rejection and infection states simultaneously, it was
convenient to define diagnostic sensitivities only. If an individ-
ual has the diagnostic state Dj, the probability of obtaining the
test classification TDj is P(TDj/Dj). This was estimated by
dividing the number of individuals in 'state Dj which have a
test classification TDj by the number of all tests in this group.
A predictive value PVDj/TDi is the probability P(Dj/TDi) that an
individual is in the diagnostic state Dj, if the test classification
is TDi. There are many predictive values. We have calculated
the predictive value PV^/roi only» representing the probability
that the test classification and diagnostic state agree. These
probabilities were estimated by dividing the number of test
classifications TDj of individuals with the diagnostic state Dj
by the number of all test classifications TPj. Predictive values
depend on the prior probabilities P(Dj) of the diagnostic state
Dj. If the prior probabilities in a study do not reflect the real
clinical prior probabilities, the real prior probabilities must be
inserted into the calculations. In our study the prior probabil-
ities of Di reflect the clinical situation, so that no additional
calculations were necessary.
Results
We included 236 endomyocardial biopsies taken from
37 patients in our study. The histological findings
were 27 χ grade 0, 74 χ grade 0.5, 79 χ grade 1.0,
22 χ grade 1.5, 31 χ grade 2.0, and 2 χ grade 2.5.
Mild rejections are common and do not need special
treatment. Therefore, we established two rejection
groups. Rejection group A contains all observations
with no histological signs of rejections (histological
grade 0) and observations with mild rejections (his-
tological grade 0.5 and 1.0) which do not need special
treatment. Group Β contains all observations with
moderate or severe rejection (histological grades 1.5,
2.0 and 2.5) which need special treatment. Nineteen
patients had one episode, 8 patients had two episodes,
and one patient had three episodes of acute rejections
(histological grade > 1.0). Nine patients never had
any acute rejection. The fraction of rejection states Β
was 0.23.
For the infection state we established three groups.
Group 1 contains all observations without detectable
infection, group 2 contains all observations with Viral
infections, and group 3 contains all observations with
bacterial, fungal, or mixed infections. The rate of viral
infection was 0.39, often without clinical symptoms.
Bacterial, fungal or mixed infections were not so
frequent, the rate being 0.13. The frequency of rejec-
tion states Β did not differ between the three infection
states (Bl 0.23, B2 0.25, B3 0.20). The classification
of the observations into the six diagnostic classes
according to the results of endomyocardial biopsies,
bacteriological, serological, viral tests, and clinical
symptoms is given in table 1. *'
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Tab. 1. Classification criteria and number of observations in










































Statistically significant differences between the mean
values of the diagnostic classes are a sign of discrim-
inatory power of the analytes. The analytes, aranti-
trypsin, a2-macroglobulin, C-reactive protein, C3, C4
in serum and neopterin in urine, had some discrimi-
natory power for the differentiation of the two rejec-
tion states, but on different scales. a2-Macroglobulin
and C3 showed discriminatory differences only in the
group 'viral infections', while neopterin in urine
showed discriminatory differences in the group 'no
infection'. There were no significant differences in the
the group 'bacterial, fungal or mixed infections', but
6 observations in the rejection group B of this infec-
tion state were too small for an adequate statistical
analysis. All analytes investigated had some discrim-
inatory power for the differentiation of the three
infection states. Between the states 'no infection' and
'viral infection', only neopterin in urine and C3
showed significant differences, whereas the mean con-
centrations of all analytes investigated were signifi-
cantly different between the states 'no infection' and
'bacterial, viral and mixed infections', as well as be-
tween the states 'viral infection' and 'bacterial, fungal
or mixed infection'. The exception was a2^macroglob-
ulin, which differed only between 'viral infections'
and 'bacterial, fungal or mixed infections'. Despite
significant differences between the mean concentra-
tions of the analytes, the distributions overlapped
considerably, so that a discrimination between the
diagnostic classes was impossible if each analyte is
viewed separately (10). In a first step we investigated
whether there was any chance of discriminating all
six diagnostic classes by a multivariate combination
of analytes in a discriminant analysis. Because all
analytes investigated had some discriminatory power
in at least one discriminating problem, all were used
as variables. Exclusion of one or more analytes re-
sulted in poorer discrimination. The diagnostic sen-
Tab. 2. Diagnostic sensitivities and predictive values of the
simultaneous differentiation of rejection and infection
states of patients with heart transplants by mulitivariate
combination of ccrantitrypsin, a2-macroglobulin, C-re-
active protein, C3, C4, and neopterin in serum and
neopterin in urine.
Diagnostic state Diagnostic Predictive
sensitivity value
P(TDj/Dj) P(Dj/TDj)
No infection, no rejection, 0.40 0.68
in need of treatment
Viral infection, no rejection, 0.49 0.57
in need of treatment
Bacterial, fungal or 0.30 0.33
mixed infection, no reaction,
in need of treatment
No infection, rejection, 0.50 0.32
in need of treatment
Viral infection, rejection, 0.32 0.26
in need of treatment
Bacterial, fungal or 0.33 0.06
mixed infection, rejection,
in need of treatment
sitivities P(TDj/Dj) and the predictive values P(Dj/
TDj) derived from the classification based on this
discriminant function are given in table 2.
Because the discrimination by this approach was not
sufficient and the diagnosis of the infection states can
be made by bacteriological, serological and virological
tests, we studied the power of multivariate combina-
tions of analytes for discriminating the rejection states
separately. We used three different discriminant func-
tions. The first function (DF-1) was derived by dis-
criminant analysis, including all observations classi-
fied into the two rejection states A and B, neglecting
the infection state of the patients. We got the best
discrimination by the combination of otj-antitrypsin,
armacroglobulin, C-reactive protein (CRP), C3, C4
in serum, and neopterin in urine. An observation was
classified in rejection class A if XA > XB and in rejec-
tion class B if XB > XA * XA and XB were calculated
as follows:
XA = -161.40 - 16.96 log (ocrantitrypsin) + 28.52
log (a2-macroglobulin) - 9.92 log (CRP) - 66.02 log
(C3) + 124.50 log (C4) + 20.78 log (neopterin in
urine)
XB = -169.80 - 13.74 log ( ,-antitrypsin) + 27.42
log (oc2-maeroglobulin) - 9.26 log (CRP) - 67.75 log
(C3) + 127.87 log (C4) + 20.66 log (neopterin in
urine)
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Tab. 3. Diagnostic sensitivities and predictive values of the discrimination between the rejection states A (no rejection, in need
















































DF-1: ccrantitrypsin, a2-macroglobulin, C-reactive protein, C3, C4 in serum, neopterin in urine
DF-2: oti-antitrypsin, C-reactive protein, C4, neopterin in urine
DF-3: a,, antitrypsin, oc2-macroglobulin, C-reactive protein, C3, C4
We studied the discriminatory power of this discrim-
inant function for the infection states 'no infection'
and 'viral infections' using the two groups as test
classes. Additionally, we studied whether the discrim-
inatory power of analytes could be improved by cal-
culating a specific discriminant function for the states
'no infections' and 'viral infections'. This is of prac-
tical relevance for cases where the infection state of
the patients is known. The discriminant function DF-
2 was derived using observations of the state 'no
infection' for discriminant analysis separately, and the
discriminant function DF-3 using observations of the
state 'viral infections' only. When computing the dis-
criminant functions, analytes were taken which have
disciminatory power for the specific problem. These
are ocj-antitrypsin, C-reative protein, C4, and neo-
pterin in urine for DF-2, and ocj-antitrypsin, a2-macro-
globulin, C-reative protein, C3 and C4 for DF-3.
Exclusion of analytes resulted in poorer discrimina-
tion, while the inclusion of additional analytes did
not improve discrimination. Diagnostic sensitivities
and predictive values derived from test classifications
based on the three discriminant functions are given
in table 3.
Endomyocardial biopsy, which is used as the reference
method in establishing the rejection states A and B,
has a random variation. The results depend on the
pathologist examining the material. The pattern of
rejection may not be uniform throughout the myo-
cardium. Additionally, there is theoretically no clear
cut-off point between rejections with a need for treat-
ment and those without a need for treatment. There-
fore, we studied the discriminatory power of the dis-
criminant function DF-1 for observations with his-
tological grades of rejection 0, 0.5 and 2.0, 2.5 sepa-
rately. The predictive value of a test classification A
for a rejection state histological grade lower than 2.0
was 0.96. The predictive value of a test classification
B for a rejection state higher than 0.5 was 0.88.
Discussion
All analytes investigated are at least locally involved
in rejection and infection processes. Both processes
are accompanied by an activation of macrophäges
which release the mediator interleukin-1. Interleukin-1
stimulates the production of acute phase proteins in
liver, including C-reactive protein, ocj-antitrypsin, and
the complement factors C3 and C4. ocj-Antitrypsin
and a2-macroglobulin are pfoteinase inhibitors, and
they are consumed by the inactivation of proteinases
which are released in rejection and infection processes.
C3 and C4 are consumed by complement activation.
Interleukin-1 also activates T-cells (15). Activated T-
cells secrete the lymphokine, -interferon, which stim-
ulates the release of neopterin from macrophäges (16,
17). There are differences in the production, the lo-
calization, the activation, and the consumption of
analytes, depending on whether the patient is suffering
rejection, viral infection, or bacterial or fungal infec-
tions; these differences should result in changes of the
circulating concentrations of the analytes, which may
provide a basis for the discrimination between rejec-
tion and infection states, using a multivariate com-
bination of analytes. From a theoretical point of view
an approach based on subject-specific reference
ranges should be more efficient for the discrimination
of the different rejection and infection states than an
approach based on group reference ranges. But the
estimation of a subject-specific reference range re-
quires at least eight individual reference values, which
must be taken during a stationary phase of the disease,
and the consecutive observations must be spaced so
that the values of the analytes are independent of each
other (18, 19). In practice it is very difficult to get
such a series of individual reference values. Variations
frequently occur in the different rejection and infec-
tion states of the patients. We therefore chose ap-
proach based on group reference values. Because the
number of heart recipients was limited, we included
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more than one observation per patient in the different
diagnostic classes. From a statistical point of view
this approach is not quite exact, due to the mixing of
intra- and inter-individual variance components.
From a practical point of view it can be accepted,
because the number of individuals in each class ex-
ceeded the maximum number of observations per
individual at least tenfold, so that a smaller intrain-
dividual variance did not substantially influence the
calculated group variance.
As expected theoretically, the six diagnostic classes
showed different patterns, but the differences between
the classes were too small for an adequate discrimi-
nation by discriminant analysis; the diagnostic sensi-
tivities with a maximum of 0.50 and the predictive
values with a maximum of 0.68 are too low to be of
practical use. We cannot recommend the multivariate
combination of analytes investigated in this study for
the simultaneous discrimination between rejection and
infection.
Infection can be diagnosed by specific tests. Therefore,
the separate diagnosis of rejection is of practical im-
portance. Neither the multivariate discriminant func-
tion derived without considering the different infec-
tion states of the patients, nor the specific multivariate
discriminant functions for the infection states 'no
infection' and Viral infections' allowed a complete
discrimination between the two states: 'no rejection
in need of treatment' and 'rejection in need of treat-
ment'. The highest diagnostic sensitivity was 0.85 and
the lowest 0.74. Therefore, the multivariate combi-
nation of analytes investigated in this study cannot
replace the endomyocardial biopsy for diagnosing
cardiac allograft rejection. But it can be useful as a
screening procedure. The predictive values of the test
classification 'rejection in need of treatment' are much
too low (0.44 to 0.67) to allow the confirmation of
the diagnosis 'rejection in need of treatment'; but they
are high enough to use such a test classification as an
indication for an endomyocardial biopsy, especially if
there are other symptoms of a possible rejection. The
predictive values of the test classification 'no rejection
in need of treatment' are high enough (0.91 to 0.94)
to allow the exclusion of a 'rejection in need of treat-
ment', if there are no clinical symptoms of an acute
cardiac allograft rejection. We suggest the use of the
discriminant function DF-1. This function does not
require any knowledge of the infection state of the
patient and results in a good classification of the
rejection states of patients without any infection and
patients with viral infections. The discriminatory
power of the discriminant function increases if inter-
mediate states of rejection are excluded and only clear
states of rejection are classified.
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